SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > SBI Mutual Fund > SBI Pharma Fund (G)

SBI Pharma Fund (G)

PLAN: Regular OPTIONS: Growth
139.865 0.95 (0.68%)

NAV as on 21 May, 2015

CRISIL MF RANK

Not Ranked

Scheme Risk Grade

  HIGH RISK

HIGH RISK

  • For investors looking at long term capital growth investments.
  • Ideal for people who wish to benefit from potentially higher returns and have the risk appetite for the same.
FUND FAMILY : SBI Mutual Fund FUND CLASS : Sector - Pharma & Healthcare
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
Holdings (Apr 30, 15)
Equity Sector Value
(Rs cr)
Assets %
Sun Pharma Pharmaceuticals 136.21 27.74
Lupin Pharmaceuticals 61.16 12.46
Aurobindo Pharm Pharmaceuticals 48.79 9.94
Natco Pharma Pharmaceuticals 34.04 6.93
Divis Labs Pharmaceuticals 31.03 6.32
Strides Arcolab Pharmaceuticals 30.89 6.29
Cadila Health Pharmaceuticals 29.70 6.05
Torrent Pharma Pharmaceuticals 28.92 5.89
Glenmark Pharmaceuticals 19.59 3.99
Sequent Scienti Pharmaceuticals 14.68 2.99
Sector Allocation (Apr 30, 15)
  Sector   % 1-Year
High Low

Pharmaceuticals

96.24 99.60 91.57
Asset Allocation (%) (Apr 30, 15)
Class
%

Equity

96.24

Others / Unlisted

0.37

Debt

0.00

Mutual Funds

N.A

Money Market

2.70

Cash / Call

0.69

Net Receivable / Payable

N.A
Concentration
Holdings
%

Top 5

63.39

Top 10

88.60
Sectors
%

Top 3

96.24
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.